[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100443403":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":23,"responsibleParty":46,"collaborators":7,"id":50,"slug":7,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":7,"eligibilityCriteria":54,"healthyVolunteers":55,"sex":56,"minAge":57,"maxAge":7,"enrollmentInfo":58,"targetDuration":61,"studyType":62,"phases":7,"briefSummary":63,"conditions":64,"keywords":7,"overallStatus":26,"whyStopped":7,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Chinese University of Hong Kong","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DIAGNOSTIC_TEST","Esophagogastroduodenoscopy","To set up a prospective study and registry (HAR-P) for patients with H. pylori infection, atrophic gastritis or intestinal metaplasia to evaluate their clinical features and outcomes. The objectives include:\n\n1. Assess the short- and long-term patient outcomes of H. pylori patients\n2. Characterize factors involved in the progression or regression of pre-neoplastic lesions, namely atrophic gastritis and intestinal metaplasia\n3. Gather information for a better understanding on the efficacy and role of surveillance\n4. Potential for the development of new screening\u002Fsurveillance strategies and tools for better risk stratification of patients\n5. Establish a biobank for H. pylori, atrophic gastritis and intestinal metaplasia patients",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Andrew Ming Yeung HO","CONTACT","26371398","andrewho@cuhk.edu.hk",{"name":20,"role":16,"phone":21,"phoneExt":7,"email":22},"Thomas Yuen Tung LAM","26370355","thomaslam@cuhk.edu.hk",[24,38],{"facility":25,"status":26,"city":27,"state":7,"zip":7,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Prince of Wales Hospital","RECRUITING","Hong Kong","HK",{"type":30,"coordinates":31},"Point",[32,33],114.17469,22.27832,{"lat":33,"lon":32},[36],{"name":37,"role":16,"phone":21,"phoneExt":7,"email":22},"Thomas Yuen Tung Lam, MSc",{"facility":39,"status":26,"city":27,"state":7,"zip":7,"country":27,"countryCode":28,"cosmosGeoPoint":40,"geoPoint":42,"contacts":43},"S.H. Ho Centre for Digestive Health, Prince of Wales Hospital",{"type":30,"coordinates":41},[32,33],{"lat":33,"lon":32},[44],{"name":45,"role":16,"phone":7,"phoneExt":7,"email":7},"Ming Yeung HO",{"type":47,"investigatorFullName":48,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Louis Ho Shing Lau","Assistant Professor","100443403",false,"NCT05053945","Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study","Inclusion Criteria:\n\n* Adults \\>= 18 years of age\n* Written informed consent obtained\n* Diagnosed with current or past H. pylori infection,\n* Histologically proven atrophic gastritis (body and\u002For antrum of stomach), intestinal metaplasia (complete and incomplete), dysplasia (any grade) and\u002For gastric cancer (post- treatment)\n\nExclusion Criteria:\n\n* Co-morbid illness that prohibit endoscopic surveillance\n* Declines for study questionnaire, biobanking of specimens and\u002For regular review per study protocol",true,"ALL","18 Years",{"count":59,"type":60},260,"ESTIMATED","3 Years","OBSERVATIONAL","Since much is unknown about factors that lead to progression of the pre-neoplastic lesions and cancer. In addition, there is ongoing debate on the optimal surveillance intervals and techniques. To solve these important clinical questions, the establishment of a registry for a longitudinal study is planned.",[65,66,67],"Helicobacter Pylori","Atrophic Gastritis","Intestinal Metaplasia","2024-08-28",{"date":70,"type":71},"2024-08-29","ACTUAL",{"date":73,"type":71},"2020-05-15",{"date":75,"type":60},"2025-12-31",{"name":5,"class":6},2]